{
    "LeadSponsorName": [
        "Pfizer",
        "Cogent Biosciences, Inc.",
        "Human Genome Sciences Inc., a GSK Company",
        "Asahi Kasei Pharma America Corporation",
        "Helsinn Healthcare SA",
        "Merck Sharp & Dohme LLC",
        "Sumitomo Pharma Oncology, Inc.",
        "Becton, Dickinson and Company",
        "R-Pharm International, LLC",
        "Uni\u00e3o Qu\u00edmica Farmac\u00eautica Nacional S/A",
        "Sanofi",
        "Mirati Therapeutics Inc.",
        "Scitech Produtos Medicos Ltda",
        "BeiGene",
        "Puma Biotechnology, Inc.",
        "bluebird bio",
        "Telik",
        "Abbott",
        "Abivax S.A.",
        "Azidus Brasil",
        "Biozeus Biopharmaceutical S.A.",
        "Celgene",
        "Wyeth is now a wholly owned subsidiary of Pfizer",
        "Nektar Therapeutics",
        "Guerbet",
        "Chiltern Pesquisa Clinica Ltda",
        "Biogen",
        "Sandoz",
        "Spectrum Pharmaceuticals, Inc",
        "Bayer",
        "Seagen Inc.",
        "HUYABIO International, LLC.",
        "AstraZeneca",
        "Anthera Pharmaceuticals",
        "Baxalta now part of Shire",
        "Basilea Pharmaceutica",
        "Humanigen, Inc.",
        "Algenis SpA",
        "Incyte Corporation",
        "Jazz Pharmaceuticals",
        "Zodiac Produtos Farmaceuticos S.A.",
        "Cellectar Biosciences, Inc.",
        "Gamida Cell ltd",
        "Immune Biosolutions Inc",
        "Otsuka Pharmaceutical Development & Commercialization, Inc.",
        "Aragon Pharmaceuticals, Inc.",
        "Novartis Pharmaceuticals",
        "Repros Therapeutics Inc.",
        "Astellas Pharma Inc",
        "Applied Biology, Inc.",
        "Morphotek",
        "mAbxience Research S.L.",
        "Ipsen",
        "Crinetics Pharmaceuticals Inc.",
        "Boehringer Ingelheim",
        "OncoVerity, Inc.",
        "Debiopharm International SA",
        "Pierre Fabre Medicament",
        "Corcept Therapeutics",
        "Alexion",
        "Janssen Vaccines & Prevention B.V.",
        "Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA",
        "R-Pharm",
        "Recepta Biopharma",
        "Brooklyn ImmunoTherapeutics, LLC",
        "Halozyme Therapeutics",
        "Sophia Genetics SAS",
        "RayzeBio, Inc.",
        "Isarna Therapeutics GmbH",
        "Tobira Therapeutics, Inc.",
        "EOM Pharmaceuticals",
        "pharmaand GmbH",
        "AbbVie (prior sponsor, Abbott)",
        "Eisai Inc.",
        "Principia Biopharma, a Sanofi Company",
        "NovoCure Ltd.",
        "PharmaMar",
        "Viracta Therapeutics, Inc.",
        "Genmab",
        "Akeso",
        "UCB BIOSCIENCES GmbH",
        "Kronos Bio",
        "Loxo Oncology, Inc.",
        "AVEO Pharmaceuticals, Inc.",
        "BioMarin Pharmaceutical",
        "Biocinese",
        "PTC Therapeutics",
        "Acerta Pharma BV",
        "Janssen-Cilag Ltd.",
        "Boston Scientific Corporation",
        "Hoffmann-La Roche",
        "Merck KGaA, Darmstadt, Germany",
        "Johnson & Johnson Pharmaceutical Research & Development, L.L.C.",
        "CanariaBio Inc.",
        "Regeneron Pharmaceuticals",
        "Taiho Oncology, Inc.",
        "Tesaro, Inc.",
        "Janssen Sciences Ireland UC",
        "Telios Pharma, Inc.",
        "Janssen Pharmaceutica N.V., Belgium",
        "Teva Branded Pharmaceutical Products R&D, Inc.",
        "OSI Pharmaceuticals",
        "ApoPharma",
        "GlaxoSmithKline",
        "Celldex Therapeutics",
        "Novo Nordisk A/S",
        "AbbVie",
        "Active Biotech AB",
        "Polyphor Ltd.",
        "Bioverativ Therapeutics Inc.",
        "Synta Pharmaceuticals Corp.",
        "Ultragenyx Pharmaceutical Inc",
        "Pfizer's Upjohn has merged with Mylan to form Viatris Inc.",
        "Alaunos Therapeutics",
        "F2G Biotech GmbH",
        "Eidos Therapeutics, a BridgeBio company",
        "Crist\u00e1lia Produtos Qu\u00edmicos Farmac\u00eauticos Ltda.",
        "Apellis Pharmaceuticals, Inc.",
        "Geron Corporation",
        "Ligand Pharmaceuticals",
        "Tolmar Inc.",
        "ColubrisMX",
        "Genentech, Inc.",
        "Daiichi Sankyo, Inc.",
        "Janssen Scientific Affairs, LLC",
        "CSL Behring",
        "Janssen Research & Development, LLC",
        "Shire",
        "Kartos Therapeutics, Inc.",
        "Xcovery Holding Company, LLC",
        "EMD Serono",
        "Agenus Inc.",
        "Janssen-Cilag Farmaceutica Ltda.",
        "Bristol-Myers Squibb",
        "Threshold Pharmaceuticals",
        "Clovis Oncology, Inc.",
        "Agios Pharmaceuticals, Inc.",
        "Libbs Farmac\u00eautica LTDA",
        "Millennium Pharmaceuticals, Inc.",
        "Myovant Sciences GmbH",
        "Amgen",
        "Exelixis",
        "Gilead Sciences",
        "Vical",
        "Advaxis, Inc.",
        "BioNTech SE",
        "Inovio Pharmaceuticals",
        "NantCell, Inc.",
        "Janssen Pharmaceutica",
        "Eli Lilly and Company",
        "Arcus Biosciences, Inc.",
        "Checkpoint Therapeutics, Inc.",
        "medac GmbH",
        "Astellas Pharma Global Development, Inc.",
        "Tularik",
        "Takeda",
        "ISA Pharmaceuticals",
        "Celcuity, Inc.",
        "OBI Pharma, Inc",
        "Immix Biopharma, Inc.",
        "Intercept Pharmaceuticals",
        "Recombio SL",
        "SciClone Pharmaceuticals",
        "Shionogi",
        "Novartis",
        "Mallinckrodt",
        "Kyowa Kirin, Inc.",
        "Sesen Bio, Inc.",
        "Genzyme, a Sanofi Company",
        "RECORDATI GROUP",
        "ViiV Healthcare",
        "Nereus Pharmaceuticals, Inc.",
        "Lavilabor Natural Products Ltd",
        "Eurofarma Laboratorios S.A.",
        "EMD Serono Research & Development Institute, Inc.",
        "UCB Pharma",
        "Merrimack Pharmaceuticals",
        "Mylan Inc.",
        "CancerVax Corporation",
        "Cryopraxis Criobiologia Ltda.",
        "Heidelberg Pharma AG"
    ]
}